(Q38085251)

28 August 2017

title

A new horizon in asthma: inhibiting ILC function (English)

1 reference

28 August 2017

1 reference

1

R Stokes Peebles

1 reference

28 August 2017

language of work or name

English

0 references

publication date

1 February 2013

1 reference

Science Translational Medicine

28 August 2017

published in

1 reference

28 August 2017

volume

5

1 reference

28 August 2017

issue

174

1 reference

28 August 2017

page(s)

174fs7

1 reference

Severe asthma: future treatments.

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005881

Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005881

Innate lymphoid cells--a proposal for uniform nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005881

Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005881

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005881

TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005881

Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005881

ATLa, an aspirin-triggered lipoxin A4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005881

Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005881

10.1126/SCITRANSLMED.3005881

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference